Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 1,674 | 135 | 901 | 2,163 | 0 |
| Gross Profit | 1,674 | 135 | 901 | 2,163 | N/A |
| Operating Expenses | 141,908 | 88,205 | 45,710 | 25,554 | 0 |
| Operating Income | -140,234 | -88,070 | -44,809 | -23,391 | N/A |
| Other Income | 68 | 367 | 1,055 | 1,873 | 0 |
| Pre-tax Income | -140,166 | -87,703 | -43,754 | -21,518 | 0 |
| Net Income Continuous | -140,166 | -87,703 | -43,754 | -21,518 | N/A |
| Net Income | $-140,166 | $-87,703 | $-43,754 | $-21,518 | $N/A |
| EPS Basic Total Ops | -14.10 | -173.03 | -133.82 | -136.46 | N/A |
| EPS Basic Continuous Ops | -14.10 | -173.03 | -133.80 | -136.19 | N/A |
| EPS Diluted Total Ops | -14.10 | -173.03 | -133.82 | -136.46 | N/A |
| EPS Diluted Continuous Ops | -14.10 | -173.03 | -133.80 | -136.19 | N/A |
| EBITDA(a) | $-135,074 | $-83,966 | $-41,809 | $-21,798 | $N/A |